The Effect of Disease Modifying Therapies on Brain Atrophy in Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis

Clinical Relevance of Brain Volume Measures in Multiple Sclerosis

(2014) Nicola De Stefano et al.   CNS DRUGS

Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis

(2013) Maria Pia Sormani et al.   ANNALS OF NEUROLOGY

Preventing brain atrophy should be the gold standard of effective therapy in MS (after the first year of treatment): Yes

(2013) Richard A Rudick et al.   Multiple Sclerosis Journal

Preventing brain atrophy should be the gold standard of effective therapy in multiple sclerosis (after the first year of treatment): Commentary

(2013) DL Arnold et al.   Multiple Sclerosis Journal

Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome

(2012) Giancarlo Comi et al.   Multiple Sclerosis Journal

Efficacy and safety of subcutaneous interferon beta-1a in relapsing–remitting multiple sclerosis: Further outcomes from the IMPROVE study

(2011) Nicola De Stefano et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

MR Imaging of Gray Matter Involvement in Multiple Sclerosis: Implications for Understanding Disease Pathophysiology and Monitoring Treatment Efficacy

(2010) M. Filippi et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Cerebral pseudoatrophy or real atrophy after therapy in multiple sclerosis

(2010) Khoury Samia et al.   ANNALS OF NEUROLOGY

Evidence for acute neurotoxicity after chemotherapy

(2010) Axel Petzold et al.   ANNALS OF NEUROLOGY

Cognition in multiple sclerosis: relevance of lesions, brain atrophy and proton MR spectroscopy

(2010) Antonio Giorgio et al.   NEUROLOGICAL SCIENCES

Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes

(2010) N. De Stefano et al.   NEUROLOGY

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

(2010) Ludwig Kappos et al.   NEW ENGLAND JOURNAL OF MEDICINE

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

(2009) Alessandro Liberati et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Quantification and clinical relevance of brain atrophy in multiple sclerosis: a review

(2009) Blandine Grassiot et al.   JOURNAL OF NEUROLOGY

Imaging outcomes for neuroprotection and repair in multiple sclerosis trials

(2009) Frederik Barkhof et al.   Nature Reviews Neurology

The place of conventional MRI and newly emerging MRI techniques in monitoring different aspects of treatment outcome

(2008) Robert Zivadinov et al.   JOURNAL OF NEUROLOGY

Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis

(2008) R. Zivadinov et al.   NEUROLOGY